During the Westminster Hall debate, triggered by the e-petition on brain tumour research, Mike Wood spoke about the urgent need for change in the way aggressive brain tumours are diagnosed, treated and researched. Referencing the experience of his senior parliamentary assistant, Dan Horrocks, he argued that the current system is failing patients and families, and called for measurable targets for clinical trials, stronger accountability and accelerated work on repurposing existing drugs.
A tighter caption version:
Mike Wood's contribution in yesterday's Westminster Hall debate on brain tumour research highlighted the urgent need for better diagnosis, more clinical trials and faster treatment innovation for glioblastoma patients.
If you want the strongest version for a video post, this is probably the best balance:
Mike Wood's contribution in yesterday's Westminster Hall debate on brain tumour research was a powerful call for change. Referencing the experience of his senior parliamentary assistant, Dan Horrocks, he highlighted the human impact behind the statistics and the urgent need for better diagnosis, more clinical trials and faster progress on new treatments. His message was clear: patients and families are not asking for miracles - they are asking for justice.
